Type 2 diabetes with osteoporosis
Conditions
Interventions
Treatment with risedronate and alfacalcidol
No treatment
Sponsors
Department of Internal Medicine 1, Shimane University School of Medicine
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Postmenopausal women with newly diagnosed osteoporosis, who visited our out clinic for education, evaluation, or treatment of type 2 diabetes, were enrolled if informed consent was obtained after a detailed explanation of the study purpose and methods.
Exclusion criteria
Exclusion criteria: Nobody had hepatic or renal dysfunction or nutritional derangements. All patients were free of drugs known to influence bone and calcium metabolism, such as vitamin D, bisphosphonate, or estrogen, up until the time of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plaque score and abdominal aortic calcification score | — |
Countries
Japan
Outcome results
None listed